Humanigen CEO optimistic on drug candidate after pulling company from the brink

09:15 EST 5 Mar 2019 | Proactive Investors

The biotech is in the early stages of work on a drug designed to reduce the sometimes dangerous side effects of a cancer therapy involving altered T cells

More From BioPortfolio on "Humanigen CEO optimistic on drug candidate after pulling company from the brink"